Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2018

Open Access 01-12-2018 | Study protocol

A randomized, controlled study to evaluate the efficacy of intra-articular, autologous adipose tissue injections for the treatment of mild-to-moderate knee osteoarthritis compared to hyaluronic acid: a study protocol

Authors: Ian A. Jones, Melissa Wilson, Ryan Togashi, Bo Han, Austin K. Mircheff, C. Thomas Vangsness JR

Published in: BMC Musculoskeletal Disorders | Issue 1/2018

Login to get access

Abstract

Background

Osteoarthritis (OA) is a highly debilitating joint disease that causes progressive, irreversible damage to articular cartilage. OA takes a massive toll on society that has grown in recent decades, but no therapy has been shown to halt or reverse the progression of the disease. The critical need for better treatments and increased interest cellular therapies has spawned a new generation of “minimally manipulated” cell treatments. Autologous adipose tissue injections are among the most controversial of these new treatments. Despite a lack of clinical evidence, adipose tissue injections are often marketed as “stem cell” injections with wide-ranging regenerative benefits. The purpose of this study is to estimate the effect size of the treatment by comparing the efficacy of autologous fat to hyaluronic acid (HA). As a secondary aim, we will test for preliminary evidence of efficacy of autologous fat vs. HA.

Methods

This is a prospective, single-center, parallel-group, randomized, controlled trial. Participants (n = 54) will receive either a single intra-articular, ultrasound-guided injection of autologous adipose tissue or a single intra-articular, ultrasound-guided injection of HA (1:1 ratio). Outcome data will be obtained at baseline, week-6 and month-6. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain domain (WOMAC-A) will be used as the primary outcome measure. Secondary clinical outcome measures include WOMAC (full), clinical anchors (pain, function, and stiffness), and the 29-point Patient-Reported Outcomes Measurement Information System (PROMIS®) profile. We will also take synovial fluid samples and assess sway velocity using a force plate, as well as analyze excess/discard adipose tissue to gain a better understanding of how intra-articular adipose tissue injections influence the biochemical environment of the joint.

Discussion

Given the widespread use of intra-articular fat injections in the United States, it is critical that randomized, controlled human studies evaluating efficacy and biological activity be performed. This study is the first step in addressing this unmet need, but it is not without limitations. The most notable limitations of this study are its small size and lack of blinding, which predisposes the study to both investigator and participant bias.

Trial registration

NCT03242707 // HS-17-00365 // Registration Date (First Posted): August 8, 2018.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lories RJ, Luyten FP. The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol. Nature Publishing Group. 2011;7:43–9.CrossRef Lories RJ, Luyten FP. The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol. Nature Publishing Group. 2011;7:43–9.CrossRef
2.
go back to reference Murphy L, Helmick CG. The impact of osteoarthritis in the United States: a population-health perspective: a population-based review of the fourth most common cause of hospitalization in U.S. adults. Orthop Nurs. 2012;31:85–91.CrossRef Murphy L, Helmick CG. The impact of osteoarthritis in the United States: a population-health perspective: a population-based review of the fourth most common cause of hospitalization in U.S. adults. Orthop Nurs. 2012;31:85–91.CrossRef
3.
go back to reference Ethgen O, Kahler KH, Kong SX, Reginster J-Y, Wolfe F. The effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: a longitudinal analysis. J Rheumatol. 2002;29:1147–55.PubMed Ethgen O, Kahler KH, Kong SX, Reginster J-Y, Wolfe F. The effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: a longitudinal analysis. J Rheumatol. 2002;29:1147–55.PubMed
4.
go back to reference Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum. Wiley subscription services, Inc., A Wiley Company. 2009;60:3546–53. Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum. Wiley subscription services, Inc., A Wiley Company. 2009;60:3546–53.
5.
go back to reference Losina E, Paltiel AD, Weinstein AM, Yelin E, Hunter DJ, Chen SP, et al. Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty. Arthritis Care Res. 2015;67:203–15.CrossRef Losina E, Paltiel AD, Weinstein AM, Yelin E, Hunter DJ, Chen SP, et al. Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty. Arthritis Care Res. 2015;67:203–15.CrossRef
6.
go back to reference Brown GA. AAOS clinical practice guideline: treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg. 2013;21:577–9. Brown GA. AAOS clinical practice guideline: treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg. 2013;21:577–9.
7.
go back to reference Maniar KH, Jones IA, Gopalakrishna R, Vangsness CT Jr. Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage. Expert Opin Pharmacother. 2018;19(2):93–102.CrossRef Maniar KH, Jones IA, Gopalakrishna R, Vangsness CT Jr. Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage. Expert Opin Pharmacother. 2018;19(2):93–102.CrossRef
8.
go back to reference Jevsevar DS. Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg. 2013;21:571–6. Jevsevar DS. Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg. 2013;21:571–6.
9.
go back to reference McAlindon TE, LaValley MP, Harvey WF, Price LL, Driban JB, Zhang M, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA Am Med Assoc. 2017;317:1967–75.CrossRef McAlindon TE, LaValley MP, Harvey WF, Price LL, Driban JB, Zhang M, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA Am Med Assoc. 2017;317:1967–75.CrossRef
10.
go back to reference Bedard NA, Pugely AJ, Elkins JM, Duchman KR, Westermann RW, Liu SS, et al. The John N. Insall award: do intraarticular injections increase the risk of infection after TKA? Clin Orthop Relat Res. Springer US. 2017;475:45–52.CrossRef Bedard NA, Pugely AJ, Elkins JM, Duchman KR, Westermann RW, Liu SS, et al. The John N. Insall award: do intraarticular injections increase the risk of infection after TKA? Clin Orthop Relat Res. Springer US. 2017;475:45–52.CrossRef
11.
go back to reference Wernecke C, Braun HJ, Dragoo JL. The Effect of Intra-articular Corticosteroids on Articular Cartilage: A Systematic Review. Orthop J Sports Med. SAGE PublicationsSage CA: Los Angeles, CA. 2015;3:2325967115581163. Wernecke C, Braun HJ, Dragoo JL. The Effect of Intra-articular Corticosteroids on Articular Cartilage: A Systematic Review. Orthop J Sports Med. SAGE PublicationsSage CA: Los Angeles, CA. 2015;3:2325967115581163.
12.
go back to reference McIntyre LF, Bannuru RR, Vaysbrot EE. Authors’ reply. Arthroscopy. 2014;30:658–9.CrossRef McIntyre LF, Bannuru RR, Vaysbrot EE. Authors’ reply. Arthroscopy. 2014;30:658–9.CrossRef
13.
go back to reference Bannuru RR, Vaysbrot EE, McIntyre LF. Did the American Academy of Orthopaedic surgeons osteoarthritis guidelines miss the mark? Arthroscopy. 2014;30:86–9.CrossRef Bannuru RR, Vaysbrot EE, McIntyre LF. Did the American Academy of Orthopaedic surgeons osteoarthritis guidelines miss the mark? Arthroscopy. 2014;30:86–9.CrossRef
14.
go back to reference Jevsevar D, Donnelly P, Brown GA, Cummins DS. Viscosupplementation for osteoarthritis of the knee: a systematic review of the evidence. J Bone Joint Surg Am. 2015;97:2047–60.CrossRef Jevsevar D, Donnelly P, Brown GA, Cummins DS. Viscosupplementation for osteoarthritis of the knee: a systematic review of the evidence. J Bone Joint Surg Am. 2015;97:2047–60.CrossRef
15.
go back to reference Vannabouathong C, Bhandari M, Bedi A, Khanna V, Yung P, Shetty V, et al. Nonoperative treatments for knee osteoarthritis: an evaluation of treatment characteristics and the intra-articular placebo effect: a systematic review. JBJS Rev. 2018;6:e5.CrossRef Vannabouathong C, Bhandari M, Bedi A, Khanna V, Yung P, Shetty V, et al. Nonoperative treatments for knee osteoarthritis: an evaluation of treatment characteristics and the intra-articular placebo effect: a systematic review. JBJS Rev. 2018;6:e5.CrossRef
16.
go back to reference Liu-Bryan R. Synovium and the innate inflammatory network in osteoarthritis progression. Curr Rheumatol Rep. Current Science Inc. 2013;15:323.CrossRef Liu-Bryan R. Synovium and the innate inflammatory network in osteoarthritis progression. Curr Rheumatol Rep. Current Science Inc. 2013;15:323.CrossRef
17.
go back to reference Haseeb A, Haqqi TM. Immunopathogenesis of osteoarthritis. Clin Immunol. 2013;146:185–96.CrossRef Haseeb A, Haqqi TM. Immunopathogenesis of osteoarthritis. Clin Immunol. 2013;146:185–96.CrossRef
18.
go back to reference Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. Nature Publishing Group. 2010;6:625–35.CrossRef Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. Nature Publishing Group. 2010;6:625–35.CrossRef
19.
go back to reference Chevalier X, Eymard F, Richette P. Biologic agents in osteoarthritis: hopes and disappointments. Nat Rev Rheumatol Nature Publishing Group. 2013;9:400–10.CrossRef Chevalier X, Eymard F, Richette P. Biologic agents in osteoarthritis: hopes and disappointments. Nat Rev Rheumatol Nature Publishing Group. 2013;9:400–10.CrossRef
20.
go back to reference Lambert C, Dubuc J-E, Montell E, Vergés J, Munaut C, Noël A, et al. Gene expression pattern of cells from inflamed and normal areas of osteoarthritis synovial membrane. Arthritis Rheumatol. 2014;66:960–8.CrossRef Lambert C, Dubuc J-E, Montell E, Vergés J, Munaut C, Noël A, et al. Gene expression pattern of cells from inflamed and normal areas of osteoarthritis synovial membrane. Arthritis Rheumatol. 2014;66:960–8.CrossRef
21.
go back to reference Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier J-P, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7:33–42.CrossRef Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier J-P, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7:33–42.CrossRef
22.
go back to reference Ashraf S, Cha B-H, Kim J-S, Ahn J, Han I, Park H, et al. Regulation of senescence associated signaling mechanisms in chondrocytes for cartilage tissue regeneration. Osteoarthr Cartil. 2016;24:196–205.CrossRef Ashraf S, Cha B-H, Kim J-S, Ahn J, Han I, Park H, et al. Regulation of senescence associated signaling mechanisms in chondrocytes for cartilage tissue regeneration. Osteoarthr Cartil. 2016;24:196–205.CrossRef
23.
go back to reference Lotz M, Martel-Pelletier J, Christiansen C, Brandi M-L, Bruyère O, Chapurlat R, et al. Value of biomarkers in osteoarthritis: current status and perspectives. Ann. Rheum. Dis. BMJ Publishing Group Ltd and European League Against Rheumatism. 2013;72:1756–63. Lotz M, Martel-Pelletier J, Christiansen C, Brandi M-L, Bruyère O, Chapurlat R, et al. Value of biomarkers in osteoarthritis: current status and perspectives. Ann. Rheum. Dis. BMJ Publishing Group Ltd and European League Against Rheumatism. 2013;72:1756–63.
24.
go back to reference Tsuchida AI, Beekhuizen M, t Hart MC, TRDJ R, WJA D, DBF S, et al. Cytokine profiles in the joint depend on pathology, but are different between synovial fluid, cartilage tissue and cultured chondrocytes. Arthritis Res. Ther. BioMed Central. 2014;16:441.CrossRef Tsuchida AI, Beekhuizen M, t Hart MC, TRDJ R, WJA D, DBF S, et al. Cytokine profiles in the joint depend on pathology, but are different between synovial fluid, cartilage tissue and cultured chondrocytes. Arthritis Res. Ther. BioMed Central. 2014;16:441.CrossRef
25.
go back to reference McIntyre JA, Jones IA, Danilkovich A, Vangsness CT. The placenta: applications in Orthopaedic sports medicine. Am J Sports Med. 2017;122:363546517697682. McIntyre JA, Jones IA, Danilkovich A, Vangsness CT. The placenta: applications in Orthopaedic sports medicine. Am J Sports Med. 2017;122:363546517697682.
26.
go back to reference Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy. 2013;15:641–8.CrossRef Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy. 2013;15:641–8.CrossRef
27.
go back to reference Turner L, Knoepfler P. Selling stem cells in the USA: assessing the direct-to-consumer industry. Cell Stem Cell. 2016;19:154–7.CrossRef Turner L, Knoepfler P. Selling stem cells in the USA: assessing the direct-to-consumer industry. Cell Stem Cell. 2016;19:154–7.CrossRef
28.
go back to reference Jones IA, Togashi RC, Thomas VC. The economics and regulation of PRP in the evolving field of orthopedic biologics. Curr Rev Musculoskelet Med Springer US. 2018;17:602–8. Jones IA, Togashi RC, Thomas VC. The economics and regulation of PRP in the evolving field of orthopedic biologics. Curr Rev Musculoskelet Med Springer US. 2018;17:602–8.
29.
go back to reference Marks P, Gottlieb S. Balancing safety and innovation for cell-based regenerative medicine. N Engl J Med. 2018;378:954–9.CrossRef Marks P, Gottlieb S. Balancing safety and innovation for cell-based regenerative medicine. N Engl J Med. 2018;378:954–9.CrossRef
30.
go back to reference Tremolada C, Ricordi C, Caplan AI, Ventura C. Mesenchymal stem cells in Lipogems, a reverse story: from clinical practice to basic science. Methods Mol. Biol. New York, NY: Springer New York. 2016;1416:109–22.CrossRef Tremolada C, Ricordi C, Caplan AI, Ventura C. Mesenchymal stem cells in Lipogems, a reverse story: from clinical practice to basic science. Methods Mol. Biol. New York, NY: Springer New York. 2016;1416:109–22.CrossRef
31.
go back to reference Clockaerts S, Bastiaansen-Jenniskens YM, Runhaar J, Van Osch GJVM, Van Offel JF, Verhaar JAN, et al. The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. Osteoarthr Cartil. 2010;18:876–82.CrossRef Clockaerts S, Bastiaansen-Jenniskens YM, Runhaar J, Van Osch GJVM, Van Offel JF, Verhaar JAN, et al. The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. Osteoarthr Cartil. 2010;18:876–82.CrossRef
32.
go back to reference Bowen JE. Technical issues in harvesting and concentrating stem cells (bone marrow and adipose). PM R. 2015;7:S8–18.CrossRef Bowen JE. Technical issues in harvesting and concentrating stem cells (bone marrow and adipose). PM R. 2015;7:S8–18.CrossRef
33.
go back to reference Vangsness CT, Sternberg H, Harris L. Umbilical cord tissue offers the greatest number of harvestable mesenchymal stem cells for research and clinical application: a literature review of different harvest sites. Arthroscopy. 2015;31:1836–43.CrossRef Vangsness CT, Sternberg H, Harris L. Umbilical cord tissue offers the greatest number of harvestable mesenchymal stem cells for research and clinical application: a literature review of different harvest sites. Arthroscopy. 2015;31:1836–43.CrossRef
34.
go back to reference Bianchi F, Maioli M, Leonardi E, Olivi E, Pasquinelli G, Valente S, et al. A new nonenzymatic method and device to obtain a fat tissue derivative highly enriched in pericyte-like elements by mild mechanical forces from human lipoaspirates. Cell Transplant. 2013;22:2063–77.CrossRef Bianchi F, Maioli M, Leonardi E, Olivi E, Pasquinelli G, Valente S, et al. A new nonenzymatic method and device to obtain a fat tissue derivative highly enriched in pericyte-like elements by mild mechanical forces from human lipoaspirates. Cell Transplant. 2013;22:2063–77.CrossRef
35.
go back to reference Carelli S, Messaggio F, Canazza A, Hebda DM, Caremoli F, Latorre E, et al. Characteristics and properties of mesenchymal stem cells derived from microfragmented adipose tissue. Cell Transplant Cognizant Communication Corporation. 2015;24:1233–52. Carelli S, Messaggio F, Canazza A, Hebda DM, Caremoli F, Latorre E, et al. Characteristics and properties of mesenchymal stem cells derived from microfragmented adipose tissue. Cell Transplant Cognizant Communication Corporation. 2015;24:1233–52.
36.
go back to reference Tonnard P, Verpaele A, Peeters G, Hamdi M, Cornelissen M, Declercq H. Nanofat grafting: basic research and clinical applications. Plast Reconstr Surg. 2013;132:1017–26.CrossRef Tonnard P, Verpaele A, Peeters G, Hamdi M, Cornelissen M, Declercq H. Nanofat grafting: basic research and clinical applications. Plast Reconstr Surg. 2013;132:1017–26.CrossRef
37.
go back to reference Bosetti M, Borrone A, Follenzi A, Messaggio F, Tremolada C, Cannas M. Human Lipoaspirate as autologous injectable active scaffold for one-step repair of cartilage defects. Cell Transplant. Cognizant Communication Corporation. 2016;25:1043–56. Bosetti M, Borrone A, Follenzi A, Messaggio F, Tremolada C, Cannas M. Human Lipoaspirate as autologous injectable active scaffold for one-step repair of cartilage defects. Cell Transplant. Cognizant Communication Corporation. 2016;25:1043–56.
38.
go back to reference Aronowitz JA, Lockhart RA, Hakakian CS. Mechanical versus enzymatic isolation of stromal vascular fraction cells from adipose tissue. Springerplus. Springer International Publishing. 2015;4:713. Aronowitz JA, Lockhart RA, Hakakian CS. Mechanical versus enzymatic isolation of stromal vascular fraction cells from adipose tissue. Springerplus. Springer International Publishing. 2015;4:713.
39.
go back to reference Shah FS, Wu X, Dietrich M, Rood J, Gimble JM. A non-enzymatic method for isolating human adipose tissue-derived stromal stem cells. Cytotherapy. 2013;15:979–85.CrossRef Shah FS, Wu X, Dietrich M, Rood J, Gimble JM. A non-enzymatic method for isolating human adipose tissue-derived stromal stem cells. Cytotherapy. 2013;15:979–85.CrossRef
40.
go back to reference Striano RD, Chen H, Bilbool N, Azatullah K, Hilado J. Non-responsive knee pain with osteoarthritis and concurrent meniscal disease treated with autologous micro-fragmented adipose tissue under continuous. CellR4. 2015;3(5):e1690. Striano RD, Chen H, Bilbool N, Azatullah K, Hilado J. Non-responsive knee pain with osteoarthritis and concurrent meniscal disease treated with autologous micro-fragmented adipose tissue under continuous. CellR4. 2015;3(5):e1690.
41.
go back to reference Franceschini M, Castellaneta C, Mineo G. Injection of autologous micro-fragmented adipose tissue for the treatment of post traumatic degenerative lesion of knee cartilage: a case report. CellR4. 2016;1768:4. Franceschini M, Castellaneta C, Mineo G. Injection of autologous micro-fragmented adipose tissue for the treatment of post traumatic degenerative lesion of knee cartilage: a case report. CellR4. 2016;1768:4.
42.
go back to reference Badylak SF. The extracellular matrix as a biologic scaffold material. Biomaterials. 2007;28:3587–93.CrossRef Badylak SF. The extracellular matrix as a biologic scaffold material. Biomaterials. 2007;28:3587–93.CrossRef
43.
go back to reference Badylak SF. The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol. 2002;13:377–83.CrossRef Badylak SF. The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol. 2002;13:377–83.CrossRef
44.
go back to reference Filardo G, Kon E, Buda R, Timoncini A, Di Martino A, Cenacchi A, et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc Springer-Verlag. 2011;19:528–35.CrossRef Filardo G, Kon E, Buda R, Timoncini A, Di Martino A, Cenacchi A, et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc Springer-Verlag. 2011;19:528–35.CrossRef
45.
go back to reference Altman RD, Akermark C, Beaulieu AD, Schnitzer T. Durolane International Study Group. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthr. Cartil. 2004;12:642–9.CrossRef Altman RD, Akermark C, Beaulieu AD, Schnitzer T. Durolane International Study Group. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthr. Cartil. 2004;12:642–9.CrossRef
46.
go back to reference Lukashev ME, Werb Z. ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol. 1998;8:437–41.CrossRef Lukashev ME, Werb Z. ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol. 1998;8:437–41.CrossRef
47.
go back to reference Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med The Rockefeller University Press. 1977;146:857–68. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med The Rockefeller University Press. 1977;146:857–68.
48.
go back to reference Heilmann HH, Lindenhayn K, Walther HU. [synovial volume of healthy and arthrotic human knee joints]. Z Orthop Ihre Grenzgeb. © 1996 F. Enke Verlag Stuttgart. 1996;134:144–8. Heilmann HH, Lindenhayn K, Walther HU. [synovial volume of healthy and arthrotic human knee joints]. Z Orthop Ihre Grenzgeb. © 1996 F. Enke Verlag Stuttgart. 1996;134:144–8.
49.
go back to reference Matziolis G, Roehner E, Windisch C, Wagner A. The volume of the human knee joint. Arch Orthop Trauma Surg. Springer Berlin Heidelberg. 2015;135:1401–3.CrossRef Matziolis G, Roehner E, Windisch C, Wagner A. The volume of the human knee joint. Arch Orthop Trauma Surg. Springer Berlin Heidelberg. 2015;135:1401–3.CrossRef
50.
go back to reference Tremolada C, Colombo V, Ventura C. Adipose tissue and mesenchymal stem cells: state of the art and Lipogems® technology development. Current stem cell reports. 2016;2:304–12.CrossRef Tremolada C, Colombo V, Ventura C. Adipose tissue and mesenchymal stem cells: state of the art and Lipogems® technology development. Current stem cell reports. 2016;2:304–12.CrossRef
51.
go back to reference Alexander RW. Autologous fat grafts as mesenchymal stromal stem cell source for use in prolotherapy: a simple technique to acquire lipoaspirants. J Prolotherapy. 2011;3:680–8. Alexander RW. Autologous fat grafts as mesenchymal stromal stem cell source for use in prolotherapy: a simple technique to acquire lipoaspirants. J Prolotherapy. 2011;3:680–8.
52.
go back to reference Vangsness Jr CT, Jack Farr I, Boyd J, Dellaero DT, Mills CR, LeRoux-Williams M. Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, Double-Blind, Controlled Study. J Bone Joint Surg Am. 2014;96(2):90–8.CrossRef Vangsness Jr CT, Jack Farr I, Boyd J, Dellaero DT, Mills CR, LeRoux-Williams M. Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, Double-Blind, Controlled Study. J Bone Joint Surg Am. 2014;96(2):90–8.CrossRef
53.
go back to reference Sánchez M, Fiz N, Azofra J, Usabiaga J, Aduriz Recalde E, Garcia Gutierrez A, et al. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy. 2012;28:1070–8.CrossRef Sánchez M, Fiz N, Azofra J, Usabiaga J, Aduriz Recalde E, Garcia Gutierrez A, et al. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy. 2012;28:1070–8.CrossRef
54.
go back to reference Chevalier X, Jerosch J, Goupille P, van Dijk N, Luyten FP, Scott DL, et al. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann. Rheum. Dis. BMJ Publishing Group Ltd. 2010;69:113–9.CrossRef Chevalier X, Jerosch J, Goupille P, van Dijk N, Luyten FP, Scott DL, et al. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann. Rheum. Dis. BMJ Publishing Group Ltd. 2010;69:113–9.CrossRef
55.
go back to reference Riddle DL, Stratford PW. Unilateral vs bilateral symptomatic knee osteoarthritis: associations between pain intensity and function. Rheumatology (Oxford). 2013;52:2229–37.CrossRef Riddle DL, Stratford PW. Unilateral vs bilateral symptomatic knee osteoarthritis: associations between pain intensity and function. Rheumatology (Oxford). 2013;52:2229–37.CrossRef
56.
go back to reference Kahn TL, Soheili AC, Schwarzkopf R. Poor WOMAC scores in contralateral knee negatively impact TKA outcomes: data from the osteoarthritis initiative. J Arthroplast. 2014;29:1580–5.CrossRef Kahn TL, Soheili AC, Schwarzkopf R. Poor WOMAC scores in contralateral knee negatively impact TKA outcomes: data from the osteoarthritis initiative. J Arthroplast. 2014;29:1580–5.CrossRef
57.
go back to reference Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833–40. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833–40.
58.
go back to reference Losina E, Ranstam J, Collins JE, Schnitzer TJ, Katz JN. OARSI clinical trials recommendations: key analytic considerations in design, analysis, and reporting of randomized controlled trials in osteoarthritis. Osteoarthr Cartil. 2015;23:677–85.CrossRef Losina E, Ranstam J, Collins JE, Schnitzer TJ, Katz JN. OARSI clinical trials recommendations: key analytic considerations in design, analysis, and reporting of randomized controlled trials in osteoarthritis. Osteoarthr Cartil. 2015;23:677–85.CrossRef
59.
go back to reference Katz P, Pedro S, Michaud K. Performance of the Patient‐Reported Outcomes Measurement Information System 29‐Item Profile in Rheumatoid Arthritis, Osteoarthritis, Fibromyalgia, and Systemic Lupus Erythematosus. Arthritis Care Res. 2017;69(9):1312–21.CrossRef Katz P, Pedro S, Michaud K. Performance of the Patient‐Reported Outcomes Measurement Information System 29‐Item Profile in Rheumatoid Arthritis, Osteoarthritis, Fibromyalgia, and Systemic Lupus Erythematosus. Arthritis Care Res. 2017;69(9):1312–21.CrossRef
60.
go back to reference Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials Elsevier. 1989;10:407–15.CrossRef Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials Elsevier. 1989;10:407–15.CrossRef
61.
go back to reference Lundquist CB, Døssing K, Christiansen DH. Responsiveness of a Danish version of the disabilities of the arm, shoulder and hand (DASH) questionnaire. Dan Med J. 2014;61:A4813.PubMed Lundquist CB, Døssing K, Christiansen DH. Responsiveness of a Danish version of the disabilities of the arm, shoulder and hand (DASH) questionnaire. Dan Med J. 2014;61:A4813.PubMed
62.
go back to reference Prieto TE, Myklebust JB, Hoffmann RG, Lovett EG, Myklebust BM. Measures of postural steadiness: differences between healthy young and elderly adults. IEEE Trans Biomed Eng. 1996;43:956–66.CrossRef Prieto TE, Myklebust JB, Hoffmann RG, Lovett EG, Myklebust BM. Measures of postural steadiness: differences between healthy young and elderly adults. IEEE Trans Biomed Eng. 1996;43:956–66.CrossRef
63.
go back to reference van Esch RW, Kool MM, van As S. NSAIDs can have adverse effects on bone healing. Med Hypotheses. 2013;81:343–6.CrossRef van Esch RW, Kool MM, van As S. NSAIDs can have adverse effects on bone healing. Med Hypotheses. 2013;81:343–6.CrossRef
65.
go back to reference McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr. Cartil. 2014;22:363–88.CrossRef McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr. Cartil. 2014;22:363–88.CrossRef
66.
go back to reference da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P, et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2017;390:e21–33.CrossRef da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P, et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2017;390:e21–33.CrossRef
67.
go back to reference Machado GC, Maher CG, Ferreira PH, Pinheiro MB, Lin C-WC, Day RO, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ. 2015;350:h1225.CrossRef Machado GC, Maher CG, Ferreira PH, Pinheiro MB, Lin C-WC, Day RO, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ. 2015;350:h1225.CrossRef
68.
go back to reference Marks PW, Witten CM, Califf RM. Clarifying stem-cell Therapy’s benefits and risks. N Engl J Med. 2017;376:1007–9.CrossRef Marks PW, Witten CM, Califf RM. Clarifying stem-cell Therapy’s benefits and risks. N Engl J Med. 2017;376:1007–9.CrossRef
69.
go back to reference Kraus VB, Conaghan PG, Aazami HA, Mehra P, Kivitz AJ, Lufkin J, et al. Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA). Osteoarthr Cartil. 2018;26:34–42.CrossRef Kraus VB, Conaghan PG, Aazami HA, Mehra P, Kivitz AJ, Lufkin J, et al. Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA). Osteoarthr Cartil. 2018;26:34–42.CrossRef
70.
go back to reference Vangsness CT, Burke WS, Narvy SJ, MacPhee RD, Fedenko AN. Human knee synovial fluid cytokines correlated with grade of knee osteoarthritis--a pilot study. Bull NYU Hosp Jt Dis. 2011;69:122–7.PubMed Vangsness CT, Burke WS, Narvy SJ, MacPhee RD, Fedenko AN. Human knee synovial fluid cytokines correlated with grade of knee osteoarthritis--a pilot study. Bull NYU Hosp Jt Dis. 2011;69:122–7.PubMed
71.
go back to reference Brazier JE, Harper R, Munro J, Walters SJ, Snaith ML. Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology (Oxford). 1999;38:870–7.CrossRef Brazier JE, Harper R, Munro J, Walters SJ, Snaith ML. Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology (Oxford). 1999;38:870–7.CrossRef
72.
go back to reference Roos EM, Toksvig-Larsen S. Knee injury and Osteoarthritis Outcome Score (KOOS) - validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes. BioMed Central. 2003;1:17.CrossRef Roos EM, Toksvig-Larsen S. Knee injury and Osteoarthritis Outcome Score (KOOS) - validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes. BioMed Central. 2003;1:17.CrossRef
73.
go back to reference Bachmeier CJ, March LM, Cross MJ, Lapsley HM, Tribe KL, Courtenay BG, et al. A comparison of outcomes in osteoarthritis patients undergoing total hip and knee replacement surgery. Osteoarthr Cartil. 2001;9:137–46.CrossRef Bachmeier CJ, March LM, Cross MJ, Lapsley HM, Tribe KL, Courtenay BG, et al. A comparison of outcomes in osteoarthritis patients undergoing total hip and knee replacement surgery. Osteoarthr Cartil. 2001;9:137–46.CrossRef
74.
go back to reference Mendicino M, Bailey AM, Wonnacott K, Puri RK, Bauer SR. MSC-based product characterization for clinical trials: an FDA perspective. Cell Stem Cell. 2014;14:141–5.CrossRef Mendicino M, Bailey AM, Wonnacott K, Puri RK, Bauer SR. MSC-based product characterization for clinical trials: an FDA perspective. Cell Stem Cell. 2014;14:141–5.CrossRef
Metadata
Title
A randomized, controlled study to evaluate the efficacy of intra-articular, autologous adipose tissue injections for the treatment of mild-to-moderate knee osteoarthritis compared to hyaluronic acid: a study protocol
Authors
Ian A. Jones
Melissa Wilson
Ryan Togashi
Bo Han
Austin K. Mircheff
C. Thomas Vangsness JR
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2018
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-018-2300-7

Other articles of this Issue 1/2018

BMC Musculoskeletal Disorders 1/2018 Go to the issue